Trials / Completed
CompletedNCT00417196
Safety, Pharmacodynamic and Pharmacokinetic Effects of QAX576 in Healthy Volunteers.
A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Single Escalating Doses of Intravenous QAX576
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study is designed to evaluate the safety, pharmacodynamic and pharmacokinetic effects of individual escalating intravenous doses of QAX576 in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | QAX576 |
Timeline
- Start date
- 2006-12-01
- Completion
- 2007-08-01
- First posted
- 2006-12-29
- Last updated
- 2010-10-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00417196. Inclusion in this directory is not an endorsement.